| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Puma Biotechnology, Inc.'s insiders have reduced their positions by a net 44,058 shares worth roughly $364K.
PBYI sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 7.26M | $64.70M | - | |
| CFO | 240.0K | $2.14M | - | |
| Other | 205.3K | $1.83M | - | |
| Dir | 54.0K | $481.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 2, 2021 | Auerbach Alan H62 | President And CEO | Sell | 1,238 | $10.14 | $12,555.55 | - | |
| Feb 2, 2021 | Nougues Maximo F61 | Chief Financial Officer | Sell | 179 | $12.26 | $2,194.67 | -1.3% | |
| Feb 2, 2021 | Auerbach Alan H62 | President And CEO | Sell | 1,222 | $12.22 | $14,930.76 | - | |
| Feb 2, 2021 | Bryce Richard Paul | See Remarks | Sell | 415 | $12.23 | $5,075.95 | -0.6% | |
| Feb 2, 2021 | Hunt Douglas M62 | See Remarks | Sell | 412 | $12.27 | $5,053.72 | -0.8% | |
| Jan 4, 2021 | Auerbach Alan H62 | President And CEO | Sell | 18,235 | $10.22 | $186,379.94 | -0.4% | |
| Jan 4, 2021 | Nougues Maximo F61 | Chief Financial Officer | Sell | 2,145 | $10.22 | $21,930.27 | -13.8% | |
| Jan 4, 2021 | Hunt Douglas M62 | See Remarks | Sell | 6,463 | $10.23 | $66,144.93 | -11.4% | |
| Jan 4, 2021 | Bryce Richard Paul | See Remarks | Sell | 6,548 | $10.23 | $67,016.16 | -8.5% | |
| Dec 2, 2020 | Bryce Richard Paul | See Remarks | Sell | 92 | $11.65 | $1,071.80 | -0.1% |